MedImmune FluMist Nasal Influenza Vaccine from Canada
FluMist live attenuated influenza vaccine administered intranasally in measured sprayers for retail. As an immunological product, it qualifies for HTS 3002.15.00.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Refrigerated nasal spray; 42-day room temp allowance
• Live virus precautions; no egg allergy contraindication
• Administration device validation for dose accuracy